Status:
UNKNOWN
Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Cognitive Decline
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The incidence of cognitive decline related to CPB ranges from 20% to 80%, which may affect length of hospital stay, quality of life, the rehabilitation process, and work performance.However, there is ...
Detailed Description
Cardiac surgery with cardiopulmonary bypass (CPB) is one of the most frequently performed operations. Neurobehavioral disorders, including neuropsychiatric and neuropsychological deficits, are a very ...
Eligibility Criteria
Inclusion
- Adult patients undergo mitral valve replacement surgery.
Exclusion
- Thrombi in left atrium, a history of symptomatic cerebrovascular disease, diabetes, psychiatric illness, renal disease, or active liver disease, less than a seven-grade education, or who cannot read.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00297245
Start Date
February 1 2006
End Date
May 1 2006
Last Update
February 28 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Union Hospital
Wuhan, Hubei, China, 430022